Vault-13

Boxer Capital Management, LLC

San Diego, CA · CIK 2018299 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2024 · limited liability company

$1.3bn reported value +74.3% vs Q1 2026
63positions
65.1%in top 10
12 new 17 added 1 reduced 3 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TANGO THERAPEUTICS INC COM TNGX TNGX 10,876,219 $340.0m25.61% 25.61% UnchangedShares held: Q3 2025 9.8m, Q4 2025 10.9m, Q1 2026 10.9m, Q2 2026 10.9m
2 REVOLUTION MEDICINES INC COM RVMD RVMD 500,000 $93.6m7.05% 7.05% UnchangedShares held: Q3 2025 400.0k, Q4 2025 400.0k, Q1 2026 500.0k, Q2 2026 500.0k
3 ABIVAX SA SPONSORED ADS ABVX ABVX 605,000 $80.6m6.07% 6.07% AddedShares held: Q3 2025 120.0k, Q4 2025 125.0k, Q1 2026 200.0k, Q2 2026 605.0k +405.0k +405,000 202.5%
4 UNIQURE NV SHS QURE QURE 1,503,300 $69.2m5.21% 5.21% AddedShares held: Q3 2025 800.0k, Q4 2025 290.0k, Q1 2026 662.0k, Q2 2026 1.5m +841.3k +841,300 127.1%
5 KODIAK SCIENCES INC COM KOD KOD 1,477,600 $57.6m4.34% 4.34% AddedShares held: Q3 2025 750.0k, Q4 2025 1.1m, Q1 2026 1.4m, Q2 2026 1.5m +116.6k +116,600 8.6%
6 KYMERA THERAPEUTICS INC COM KYMR KYMR 429,100 $49.2m3.71% 3.71% AddedShares held: Q3 2025 319.1k, Q4 2025 329.1k, Q1 2026 329.1k, Q2 2026 429.1k +100.0k +100,000 30.4%
7 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 998,500 $47.0m3.54% 3.54% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 598.5k, Q2 2026 998.5k +400.0k +400,000 66.8%
8 REPLIMUNE GROUP INC COM REPL REPL 3,983,000 $44.1m3.32% 3.32% AddedShares held: Q3 2025 1.1m, Q4 2025 750.0k, Q1 2026 1.2m, Q2 2026 4.0m +2.8m +2,808,000 239.0%
9 CELCUITY INC COM CELC CELC 416,530 $43.6m3.28% 3.28% AddedShares held: Q3 2025 90.0k, Q4 2025 225.0k, Q1 2026 225.0k, Q2 2026 416.5k +191.5k +191,530 85.1%
10 Q32 BIO INC COM QTTB QTTB 3,149,310 $40.1m3.02% 3.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.1m
11 CAPRICOR THERAPEUTICS INC COM NEW CAPR CAPR 1,395,156 $33.6m2.53% 2.53% AddedShares held: Q3 2025 0, Q4 2025 325.0k, Q1 2026 590.0k, Q2 2026 1.4m +805.2k +805,156 136.5%
12 PRECIGEN INC COM PGEN PGEN 5,150,000 $29.4m2.21% 2.21% AddedShares held: Q3 2025 850.0k, Q4 2025 1.4m, Q1 2026 3.5m, Q2 2026 5.2m +1.6m +1,650,000 47.1%
13 CORCEPT THERAPEUTICS INC COM CORT CORT 335,500 $29.2m2.20% 2.20% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 250.0k, Q2 2026 335.5k +85.5k +85,500 34.2%
14 SURROZEN INC COM NEW SRZN SRZN 1,105,683 $27.0m2.03% 2.03% AddedShares held: Q3 2025 0, Q4 2025 416.1k, Q1 2026 766.3k, Q2 2026 1.1m +339.4k +339,365 44.3%
15 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 170,000 $20.8m1.57% 1.57% UnchangedShares held: Q3 2025 110.0k, Q4 2025 170.0k, Q1 2026 170.0k, Q2 2026 170.0k
16 VIR BIOTECHNOLOGY INC COM VIR VIR 1,866,000 $19.0m1.43% 1.43% UnchangedShares held: Q3 2025 0, Q4 2025 625.0k, Q1 2026 1.9m, Q2 2026 1.9m
17 VAXCYTE INC COM PCVX PCVX 325,000 $18.9m1.42% 1.42% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 325.0k, Q2 2026 325.0k
18 UROGEN PHARMA LTD COM URGN URGN 500,000 $18.4m1.39% 1.39% UnchangedShares held: Q3 2025 575.0k, Q4 2025 500.0k, Q1 2026 500.0k, Q2 2026 500.0k
19 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 1,100,000 $16.4m1.24% 1.24% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.1m
20 PTC THERAPEUTICS INC COM PTCT PTCT 200,000 $16.3m1.23% 1.23% UnchangedShares held: Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 200.0k, Q2 2026 200.0k
21 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 46,457 $15.6m1.17% 1.17% UnchangedShares held: Q3 2025 0, Q4 2025 46.5k, Q1 2026 46.5k, Q2 2026 46.5k
22 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 800,000 $14.4m1.08% 1.08% UnchangedShares held: Q3 2025 900.0k, Q4 2025 800.0k, Q1 2026 800.0k, Q2 2026 800.0k
23 OCULAR THERAPEUTIX INC COM OCUL OCUL 1,300,000 $12.8m0.96% 0.96% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 350.0k, Q2 2026 1.3m +950.0k +950,000 271.4%
24 OPUS GENETICS INC COM IRD IRD 2,815,000 $11.6m0.87% 0.87% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.2m, Q2 2026 2.8m +565.0k +565,000 25.1%
25 PALISADE BIO INC COM PALI PALI 4,799,875 $10.0m0.76% 0.76% UnchangedShares held: Q3 2025 0, Q4 2025 4.8m, Q1 2026 4.8m, Q2 2026 4.8m
26 APOGEE THERAPEUTICS INC COM COM 70,000 $9.3m0.70% 0.70% UnchangedShares held: Q3 2025 50.0k, Q4 2025 70.0k, Q1 2026 70.0k, Q2 2026 70.0k
27 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 100,000 $8.9m0.67% 0.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 100.0k
28 COGENT BIOSCIENCES INC COM COGT COGT 225,000 $8.7m0.66% 0.66% UnchangedShares held: Q3 2025 0, Q4 2025 225.0k, Q1 2026 225.0k, Q2 2026 225.0k
29 CYTOKINETICS INC COM NEW CYTK CYTK 100,000 $8.5m0.64% 0.64% UnchangedShares held: Q3 2025 200.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
30 RELAY THERAPEUTICS INC COM RLAY RLAY 450,000 $8.4m0.63% 0.63% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 450.0k
31 CRESCENT BIOPHARMA INC. COM COM 453,686 $8.2m0.62% 0.62% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 453.7k, Q2 2026 453.7k
32 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 494,000 $8.1m0.61% 0.61% UnchangedShares held: Q3 2025 0, Q4 2025 494.0k, Q1 2026 494.0k, Q2 2026 494.0k
33 KAZIA THERAPEUTICS LTD SPONSORED ADS KZIA KZIA 560,000 $7.9m0.59% 0.59% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 560.0k
34 SHATTUCK LABS INC COM STTK STTK 1,000,000 $6.9m0.52% 0.52% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.0m
35 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 375,000 $6.9m0.52% 0.52% AddedShares held: Q3 2025 125.0k, Q4 2025 275.0k, Q1 2026 300.0k, Q2 2026 375.0k +75.0k +75,000 25.0%
36 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 274,500 $5.8m0.44% 0.44% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 274.5k
37 RELMADA THERAPEUTICS INC COM RLMD RLMD 842,106 $5.8m0.44% 0.44% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 842.1k, Q2 2026 842.1k
38 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 275,000 $5.4m0.40% 0.40% UnchangedShares held: Q3 2025 250.0k, Q4 2025 275.0k, Q1 2026 275.0k, Q2 2026 275.0k
39 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 900,000 $5.3m0.40% 0.40% UnchangedShares held: Q3 2025 0, Q4 2025 50.0k, Q1 2026 900.0k, Q2 2026 900.0k
40 CYBIN INC COM NEW COM NEW 790,000 $5.2m0.39% 0.39% AddedShares held: Q3 2025 0, Q4 2025 715.0k, Q1 2026 640.0k, Q2 2026 790.0k +150.0k +150,000 23.4%
41 ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX ODTX 275,000 $5.1m0.39% 0.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 275.0k
42 IMMATICS N.V SHS IMTX IMTX 475,000 $4.8m0.36% 0.36% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 475.0k
43 FAETH THERAPEUTICS INC COM NEW FTH FTH 180,505 $4.5m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 180.5k
44 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 75,000 $4.0m0.30% 0.30% UnchangedShares held: Q3 2025 0, Q4 2025 75.0k, Q1 2026 75.0k, Q2 2026 75.0k
45 ORIC PHARMACEUTICALS INC COM ORIC ORIC 350,000 $3.8m0.29% 0.29% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 176.5k, Q2 2026 350.0k +173.5k +173,500 98.3%
46 AN2 THERAPEUTICS INC COM ANTX ANTX 749,035 $3.6m0.27% 0.27% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 749.0k, Q2 2026 749.0k
47 NEUMORA THERAPEUTICS INC. COM NMRA NMRA 2,000,000 $3.4m0.26% 0.26% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
48 INOVIO PHARMACEUTICALS INC COM SHS INO INO 2,844,994 $3.1m0.24% 0.24% AddedShares held: Q3 2025 2.3m, Q4 2025 2.4m, Q1 2026 2.4m, Q2 2026 2.8m +474.9k +474,872 20.0%
49 ALLOGENE THERAPEUTICS INC COM ALLO ALLO 1,500,000 $3.1m0.23% 0.23% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.7m, Q2 2026 1.5m -1.2m -1,225,000 -45.0%
50 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 300,000 $3.0m0.23% 0.23% UnchangedShares held: Q3 2025 600.0k, Q4 2025 300.0k, Q1 2026 300.0k, Q2 2026 300.0k
51 KARYOPHARM THERAPEUTICS INC COM NEW KPTI KPTI 302,536 $3.0m0.22% 0.22% UnchangedShares held: Q3 2025 0, Q4 2025 252.5k, Q1 2026 302.5k, Q2 2026 302.5k
52 CLENE INC COM NEW CLNN CLNN 477,515 $2.9m0.22% 0.22% UnchangedShares held: Q3 2025 0, Q4 2025 199.7k, Q1 2026 477.5k, Q2 2026 477.5k
53 SAREPTA THERAPEUTICS INC COM SRPT SRPT 150,000 $2.7m0.20% 0.20% UnchangedShares held: Q3 2025 250.0k, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
54 MAPLIGHT THERAPEUTICS INC COM MPLT MPLT 75,000 $2.7m0.20% 0.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 75.0k
55 NURIX THERAPEUTICS INC COM NRIX NRIX 100,000 $2.4m0.18% 0.18% UnchangedShares held: Q3 2025 175.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
56 LB PHARMACEUTICALS INC COM SHS LBRX LBRX 70,000 $2.3m0.17% 0.17% UnchangedShares held: Q3 2025 70.0k, Q4 2025 70.0k, Q1 2026 70.0k, Q2 2026 70.0k
57 EDESA BIOTECH INC COM NEW EDSA EDSA 205,000 $1.7m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 205.0k
58 INVIVYD INC COM IVVD IVVD 1,500,000 $1.3m0.10% 0.10% UnchangedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m
59 UPSTREAM BIO INC COM UPB UPB 150,000 $1.0m0.08% 0.08% UnchangedShares held: Q3 2025 0, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
60 MILESTONE PHARMACEUTICALS IN COM MIST MIST 666,666 $893.3k0.07% 0.07% UnchangedShares held: Q3 2025 666.7k, Q4 2025 666.7k, Q1 2026 666.7k, Q2 2026 666.7k
61 PEPGEN INC COM PEPG PEPG 272,892 $491.2k0.04% 0.04% UnchangedShares held: Q3 2025 250.0k, Q4 2025 373.9k, Q1 2026 272.9k, Q2 2026 272.9k
62 REGENXBIO INC COM RGNX RGNX 15,000 $179.7k0.01% 0.01% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 15.0k, Q2 2026 15.0k
63 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 66,666 $1.1k0.00% 0.00% UnchangedShares held: Q3 2025 66.7k, Q4 2025 66.7k, Q1 2026 66.7k, Q2 2026 66.7k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TERNS PHARMACEUTICALS INC 375,000 $19.8m375.0k shares
SOLENO THERAPEUTICS INC SLNO SLNO 200,000 $6.7m200.0k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 20,400 $410.7k20.4k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
Q32 BIO INC QTTB · 13G · filed 2026-07-10 QTTB 13.3%≈ $40.1m new 13G 2026-07-10
SURROZEN INC SRZN · 13G · filed 2026-10-07 SRZN 11.6%≈ $35.3m +2.7 pts 13G 2026-10-07